Invinity Energy Systems plc (LSE:IES) has secured an agreement to supply 4 MWh of its VS3 vanadium flow batteries to Central European Vanadium Storage Kft, a subsidiary of Ideona Group, for two solar-plus-storage projects in Hungary. This order follows a previous purchase from Ideona, further strengthening Invinity’s presence in the Hungarian energy storage market. The batteries are scheduled for shipment in the fourth quarter of 2025 and are expected to help smooth solar generation and improve grid flexibility.
The transaction underscores the rising demand for Invinity’s long-duration storage technology and highlights the company’s broader strategy to expand across Central Europe.
Despite this progress, Invinity continues to face financial headwinds, with declining revenues and ongoing losses weighing on its valuation. Technical indicators show a mixed picture, offering some short-term bullish momentum, but long-term challenges remain due to negative earnings and the absence of dividends.
About Invinity Energy Systems
Invinity Energy Systems plc is a leading manufacturer of vanadium flow batteries, designed for large-scale and intensive energy storage applications in commercial, industrial, and utility sectors. Known for durability and the ability to operate continuously for more than 30 years without degradation, the company’s batteries are particularly suited for renewable energy integration. Formed in 2020 through the merger of redT energy plc and Avalon Battery Corporation, Invinity operates globally, with a presence in the UK, Canada, the US, and China.
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Leave a Reply